Established in 2006, SurgiQuest develops, manufactures and markets advanced access technologies for minimally invasive surgery.

The company produces patented AirSeal system, an integrated access management technology for use in laparoscopic and robotic procedures.

The system features valve-free trocar with continuous pressure sensing and an integrated insufflator and smoke evacuator.

According to Conmed, AnchorPort, Low Impact Laparoscopy, AirSeal and SurgiQuest are registered trademarks of SurgiQuest.

Conmed president and CEO Curt Hart said: "Revitalizing the Advanced Surgical business is a key element of our general surgery strategy, and this transformative acquisition uniquely bolsters the progress we have made.

"The AirSeal system is a highly differentiated technology which is fast becoming the standard of care in laparoscopic and robotic surgery where it delivers benefits for the patient, the surgeon, and the hospital."

SurgiQuest founder and CEO Kurt Azarbarzin said: "We believe that the combination of our organizations’ salesforces, the addition of our research and development expertise, as well as our keen focus on innovation, will enable us to expand our collective market share and to provide distinctively better solutions that improve both the doctor and patient experience."

Subject to customary closing conditions, the deal is expected to complete in the first quarter of 2016.

Conmed provides surgical devices and equipment for a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.

Image: Conmed to acquire privately-held SurgiQuest. Photo: courtesy of PinkBlue /